NEW YORK, March 14 - Gene Logic on Thursday said that Artesian Therapeutics has subscribed to its GeneExpress cardiovascular data suite.
The privately held biopharmaceutical company will use the database as a "primary reference source" in its cardiovascular drug-discovery and -development efforts.
Financial details of the multiyear deal were not disclosed.
According to Gene Logic, its cardiovascular data suite contains samples of a variety of cardiac and vascular diseases. The company added that "over time" it hopes to include in vitro and in vivo animal models.